Novo Nordisk suspended from leading UK trade group over obesity marketing 'breach'
Novo Nordisk was slapped with a two-year suspension from the UK pharma industry group, the Association of the British Pharmaceutical Industry (ABPI), on Thursday for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.